Cargando…

Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors

BACKGROUND: In this study we determined if treatment combining radiation therapy (RT) with intracerebral (i.c.) administration of carboplatin to F98 glioma bearing rats could improve survival over that previously reported by us with a 15 Gy dose (5 Gy × 3) of 6 MV photons. METHODS: First, in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Weilian, Barth, Rolf F, Huo, Tianyao, Nakkula, Robin J, Weldon, Michael, Gupta, Nilendu, Agius, Lawrence, Grecula, John C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898032/
https://www.ncbi.nlm.nih.gov/pubmed/24422671
http://dx.doi.org/10.1186/1748-717X-9-25
_version_ 1782300346361577472
author Yang, Weilian
Barth, Rolf F
Huo, Tianyao
Nakkula, Robin J
Weldon, Michael
Gupta, Nilendu
Agius, Lawrence
Grecula, John C
author_facet Yang, Weilian
Barth, Rolf F
Huo, Tianyao
Nakkula, Robin J
Weldon, Michael
Gupta, Nilendu
Agius, Lawrence
Grecula, John C
author_sort Yang, Weilian
collection PubMed
description BACKGROUND: In this study we determined if treatment combining radiation therapy (RT) with intracerebral (i.c.) administration of carboplatin to F98 glioma bearing rats could improve survival over that previously reported by us with a 15 Gy dose (5 Gy × 3) of 6 MV photons. METHODS: First, in order to reduce tumor interstitial pressure, a biodistribution study was carried out to determine if pretreatment with dexamethasone alone or in combination with mannitol and furosemide (DMF) would increase carboplatin uptake following convection enhanced delivery (CED). Next, therapy studies were carried out in rats that had received carboplatin either by CED over 30 min (20 μg) or by Alzet pumps over 7 d (84 μg), followed by RT using a LINAC to deliver either 20 Gy (5 Gy × 4) or 15 Gy (7.5 Gy × 2) dose at 6 or 24 hrs after drug administration. Finally, a study was carried out to determine if efficacy could be improved by decreasing the time interval between drug administration and RT. RESULTS: Tumor carboplatin values for D and DMF-treated rats were 9.4 ±4.4 and 12.4 ±3.2 μg/g, respectively, which were not significantly different (P = 0.14). The best survival data were obtained by combining pump delivery with 5 Gy × 4 of X-irradiation with a mean survival time (MST) of 107.7 d and a 43% cure rate vs. 83.6 d with CED vs. 30-35 d for RT alone and 24.6 d for untreated controls. Treatment-related mortality was observed when RT was initiated 6 h after CED of carboplatin and RT was started 7 d after tumor implantation. Dividing carboplatin into two 10 μg doses and RT into two 7.5 Gy fractions, administered 24 hrs later, yielded survival data (MST 82.1 d with a 25% cure rate) equivalent to that previously reported with 5 Gy × 3 and 20 μg of carboplatin. CONCLUSIONS: Although the best survival data were obtained by pump delivery, CED was highly effective in combination with 20 Gy, or as previously reported, 15 Gy, and the latter would be preferable since it would produce less late tissue effects.
format Online
Article
Text
id pubmed-3898032
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38980322014-01-23 Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors Yang, Weilian Barth, Rolf F Huo, Tianyao Nakkula, Robin J Weldon, Michael Gupta, Nilendu Agius, Lawrence Grecula, John C Radiat Oncol Research BACKGROUND: In this study we determined if treatment combining radiation therapy (RT) with intracerebral (i.c.) administration of carboplatin to F98 glioma bearing rats could improve survival over that previously reported by us with a 15 Gy dose (5 Gy × 3) of 6 MV photons. METHODS: First, in order to reduce tumor interstitial pressure, a biodistribution study was carried out to determine if pretreatment with dexamethasone alone or in combination with mannitol and furosemide (DMF) would increase carboplatin uptake following convection enhanced delivery (CED). Next, therapy studies were carried out in rats that had received carboplatin either by CED over 30 min (20 μg) or by Alzet pumps over 7 d (84 μg), followed by RT using a LINAC to deliver either 20 Gy (5 Gy × 4) or 15 Gy (7.5 Gy × 2) dose at 6 or 24 hrs after drug administration. Finally, a study was carried out to determine if efficacy could be improved by decreasing the time interval between drug administration and RT. RESULTS: Tumor carboplatin values for D and DMF-treated rats were 9.4 ±4.4 and 12.4 ±3.2 μg/g, respectively, which were not significantly different (P = 0.14). The best survival data were obtained by combining pump delivery with 5 Gy × 4 of X-irradiation with a mean survival time (MST) of 107.7 d and a 43% cure rate vs. 83.6 d with CED vs. 30-35 d for RT alone and 24.6 d for untreated controls. Treatment-related mortality was observed when RT was initiated 6 h after CED of carboplatin and RT was started 7 d after tumor implantation. Dividing carboplatin into two 10 μg doses and RT into two 7.5 Gy fractions, administered 24 hrs later, yielded survival data (MST 82.1 d with a 25% cure rate) equivalent to that previously reported with 5 Gy × 3 and 20 μg of carboplatin. CONCLUSIONS: Although the best survival data were obtained by pump delivery, CED was highly effective in combination with 20 Gy, or as previously reported, 15 Gy, and the latter would be preferable since it would produce less late tissue effects. BioMed Central 2014-01-14 /pmc/articles/PMC3898032/ /pubmed/24422671 http://dx.doi.org/10.1186/1748-717X-9-25 Text en Copyright © 2014 Yang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Yang, Weilian
Barth, Rolf F
Huo, Tianyao
Nakkula, Robin J
Weldon, Michael
Gupta, Nilendu
Agius, Lawrence
Grecula, John C
Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
title Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
title_full Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
title_fullStr Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
title_full_unstemmed Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
title_short Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
title_sort radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898032/
https://www.ncbi.nlm.nih.gov/pubmed/24422671
http://dx.doi.org/10.1186/1748-717X-9-25
work_keys_str_mv AT yangweilian radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors
AT barthrolff radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors
AT huotianyao radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors
AT nakkularobinj radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors
AT weldonmichael radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors
AT guptanilendu radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors
AT agiuslawrence radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors
AT greculajohnc radiationtherapycombinedwithintracerebraladministrationofcarboplatinforthetreatmentofbraintumors